A

Apellis Pharmaceuticals
D

APLS

23.800
USD
0.67
(2.90%)
مغلق
حجم التداول
0
الربح لكل سهم
1
العائد الربحي
-
P/E
-13
حجم السوق
3,005,699,858
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ شهر
buy
2025-09-03 02:40
APLS Chart
المزيد
أصول ذات صلة الأخبار المقالات

العنوان: Apellis Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.